Growth Metrics

InspireMD (NSPR) Gross Profit (2016 - 2025)

InspireMD filings provide 16 years of Gross Profit readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 151.6% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 75.9% increase, with the full-year FY2025 number at $2.6 million, up 75.9% from a year prior.
  • Gross Profit hit $1.2 million in Q4 2025 for InspireMD, up from $864000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.2 million in Q4 2025 to a low of $92000.0 in Q3 2021.
  • Median Gross Profit over the past 5 years was $348500.0 (2022), compared with a mean of $391650.0.
  • The widest YoY moves for Gross Profit: up 318.33% in 2021, down 69.13% in 2021.
  • InspireMD's Gross Profit stood at $294000.0 in 2021, then crashed by 32.65% to $198000.0 in 2022, then soared by 155.05% to $505000.0 in 2023, then fell by 7.13% to $469000.0 in 2024, then skyrocketed by 151.6% to $1.2 million in 2025.
  • The last three reported values for Gross Profit were $1.2 million (Q4 2025), $864000.0 (Q3 2025), and $313000.0 (Q2 2025) per Business Quant data.